Federal Legislation Tracker

A bill to modernize clinical trials and remove barriers for participation in clinical trials.

This bill is a comprehensive and strategic legislative roadmap that aims to eliminate racial and ethnic health inequities.

This bill is the Promoting Resources to Expand Vaccination, Education and New Treatments for HPV Cancers Act or the PREVENT HPV Cancers Act with the ultimate goal of preventing HPV-related cancers.

This is a bill to prove 5% real funding increases to National Institutes of Health (NIH), Centers for Disease Control (CDC), Department of Defense (DoD) medical research, and Department of Veterans Affairs (VA) medical research for each of the next ten fiscal years.

The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act would ensure prompt access to FDA-approved multi-cancer screening tests and fuel innovation in cancer screening. Read more about the legislation with this summary from Prevent Cancer.

The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act (H.R. 4189/S.2016) was initially introduced in 2016. Reintroduced in 2023, the comprehensive, bicameral, and widely supported bill aims to expand the telehealth services covered by Medicare and to maintain and bolster the progress made during the COVID-19 pandemic.

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings. Here is a one pager about the bill from Facing Our Risk of Cancer Empowered (FORCE).

This bill expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner.

The bill also allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.

This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications.

A bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes.

This legislation would protect and strengthen the 340B program by codifying 340B providers’ ability to use contract pharmacies to dispense 340B discounted drugs.

This bill requires a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a health insurance issuer.

A request for such an exception to the protocol must be granted if (1) an otherwise required treatment has been ineffective, (2) such treatment is expected to be ineffective and delaying effective treatment would lead to irreversible consequences, (3) such treatment will cause or is likely to cause an adverse reaction to the individual, (4) such treatment is expected to prevent the individual from performing daily activities or occupational responsibilities, (5) the individual is stable based on the prescription drugs already selected, or (6) there are other circumstances as determined by the Employee Benefits Security Administration.

The bill requires a group health plan to implement and make readily available a clear process for an individual to request an exception to the protocol, including required information and criteria for granting an exception. The bill further specifies timelines under which plans must respond to such requests.

This legislation aims to exempt all payments received by participants in clinical trials from being counted towards their gross income.

This bill temporarily authorizes the interstate provision of mental health telehealth services during a declared national emergency.

Specifically, subject to scope of practice and other requirements, a health care professional may provide mental health services via telehealth in any U.S. jurisdiction based on that individual's authorization to practice in any one state or territory.

The bill also provides certain related powers to health care professional regulatory bodies, such as medical boards. Specifically, a regulatory body may investigate and take disciplinary actions against a professional who provides services pursuant to this bill to a patient in that body's jurisdiction.

This bill would authorize appropriations for offsetting the costs related to reductions in research productivity resulting from the coronavirus pandemic.

Description for 117th Congress: To conduct or support cancer research, the bill would appropriate, for each of fiscal years 2023 through 2027, to the National Institutes of Health, out of amounts in the Treasury not otherwise appropriated, an amount that is equal to 25 percent of the total amount allocated to the National Institutes of Health for cancer research for fiscal year 2021, to remain available until expended. Amounts appropriated pursuant to the preceding sentence shall be in addition to amounts otherwise made available to the National Institutes of Health for cancer research.

This is legislation to amend title XIX of the Social Security Act to require coverage under State plans under the Medicaid program for annual lung cancer screening with no cost sharing for individuals for whom screening is recommended by U.S. Preventive Services Task Force guidelines, to expand coverage under Medicaid of counseling and pharmacotherapy for cessation of tobacco use, and for other purposes.